GRIFAGNI, DEBORAH
GRIFAGNI, DEBORAH
Chimica 'Ugo Schiff' - DICUS
Mostra
records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.01 secondi).
1H, 13C and 15N assignment of the human mitochondrial paramagnetic iron-sulfur protein CISD3
2022 Silva, José Malanho; Grifagni, Deborah; Cantini, Francesca; Piccioli, Mario
CIAO3 protein forms a stable ternary complex with two key players of the human cytosolic iron–sulfur cluster assembly machinery
2020 Maione V.; Grifagni D.; Torricella F.; Cantini F.; Banci L.
Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs
2022 Massai, Lara; Grifagni, Deborah; De Santis, Alessia; Geri, Andrea; Cantini, Francesca; Calderone, Vito; Banci, Lucia; Messori, Luigi
Relaxation-based NMR assignment: Spotlights on ligand binding sites in human CISD3
2023 Grifagni D.; Silva J.M.; Cantini F.; Piccioli M.; Banci L.
SARS-CoV-2 Mproinhibition by a zinc ion: structural features and hints for drug design
2021 Grifagni D.; Calderone V.; Giuntini S.; Cantini F.; Fragai M.; Banci L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1H, 13C and 15N assignment of the human mitochondrial paramagnetic iron-sulfur protein CISD3 | 2022 | Silva, José Malanho; Grifagni, Deborah; Cantini, Francesca; Piccioli, Mario | |
| CIAO3 protein forms a stable ternary complex with two key players of the human cytosolic iron–sulfur cluster assembly machinery | 2020 | Maione V.; Grifagni D.; Torricella F.; Cantini F.; Banci L. | |
| Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs | 2022 | Massai, Lara; Grifagni, Deborah; De Santis, Alessia; Geri, Andrea; Cantini, Francesca; Calderone, Vito; Banci, Lucia; Messori, Luigi | |
| Relaxation-based NMR assignment: Spotlights on ligand binding sites in human CISD3 | 2023 | Grifagni D.; Silva J.M.; Cantini F.; Piccioli M.; Banci L. | |
| SARS-CoV-2 Mproinhibition by a zinc ion: structural features and hints for drug design | 2021 | Grifagni D.; Calderone V.; Giuntini S.; Cantini F.; Fragai M.; Banci L. |